Biotech & Pharma | EMEA | CSG Talent

Our Talent Expertise in Biotech & Pharma

DELIVERING EXCEPTIONAL SENIOR LEVEL TALENT IN

Biotech & Pharma

Within Biotech & Pharma, many companies are struggling to attract and retain executives with the right experience, business development, commercialization and with a sufficiently entrepreneurial mindset. Clinical-development expertise is also in short supply.

The talent pool has been growing in recent years, particularly in the United States, with Europe, and other regions still behind. Some companies are establishing strategies to target the widest talent pool possible, such as the European biotechs that have set up US affiliates and distributed their business-development, access, marketing, and strategy teams across continents. Other biotechs are experimenting with outsourcing models, keeping select talent in-house but looking outside the organization for multiple specialist capabilities. Whichever approach organisations choose to pursue, their ability to build, attract, and retain biotech talent will be fundamental to their success.

CSG Talent work closely with leading Biotech & Pharma companies to support on their talent strategies - whether that is identifying and attracting talent across continents or targeting specialist technical talent. We have a track record of success in placing senior level roles across Europe, US, MENA and APAC.

Biotech & Pharma Recruitment Specialists

CSG's specialist Biotech & Pharma recruitment consultants operate in niche sectors and cover a range of senior level roles including Commercial, Technical, Engineering, R&D, Regulatory, Country level and Regional level Management roles and C-Level executives.

Meet Your Experts

Meet CSG Talent's consultants who specialise within Biotech & Pharma recruitment.

Meet the Wider Team

Latest Insights

06.Sep.2019

3D printing, also known as additive manufacturing, has become a fascinating topic for those operating in the spinal surgery space and one that could potentially transform the industry over the next decade. Production of additively manufactur...

Contact Us

Get In touch